Review

The Therapeutic Potential of Milk Thistle in Diabetes

Christos E. Kazazis¹, Angelos A. Evangelopoulos², Aris Kollas³, Natalia G. Vallianou³

Manuscript submitted August 1, 2014; resubmitted August 7, 2014; accepted August 8, 2014.

Keywords: type 2 diabetes, HbA1c, milk thistle, silibin, anti-diabetic, bioavailability, PPAR gamma

Abstract

Milk thistle has been known for more than 2.000 years as a herbal remedy for a variety of disorders. It has mainly been used to treat liver and gallbladder diseases. Silibum marianum, the Latin term for the plant, and its seeds contain a whole family of natural compounds, called flavonolignans. Silimarin is a dry mixture of these compounds; it is extracted after processing with ethanol, methanol, and acetone. Silimarin contains mainly silibin A, silibin B, taxifolin, isosilibin A, isosilibin B, silichristin A, silidianin, and other compounds in smaller concentrations. Apart from its use in liver and gallbladder disorders, milk thistle has recently gained attention due to its hypoglycemic and hypolipidemic properties. Recently, a substance from milk thistle has been shown to possess peroxisome proliferator-activated receptor γ (PPARγ) agonist properties. PPARγ is the molecular target of thiazolidinediones, which are used clinically as insulin sensitizers to lower blood glucose levels in diabetes type 2 patients. The thiazolidinedione type of PPARγ ligands is an agonist with a very high binding affinity. However, this ligand type demonstrates a range of undesirable side effects, thus necessitating the search for new effective PPARγ agonists. Interestingly, studies indicate that partial agonism of PPARγ induces promising activity patterns by retaining the positive effects attributed to the full agonists, with reduced side effects. In this review, the therapeutic potential of milk thistle in the management of diabetes and its complications are discussed.

Fulltext: HTML , PDF (287KB)

This article has been cited by other articles:

	Herbal Medications in Cardiovascular Medicine Liperoti R, Vetrano DL, Bernabei R, Onder G J Am Coll Cardiol 2017. 69(9):1188-1199
	New amides from seeds of Silybum marianum with potential antioxidant and antidiabetic activities Qin NB, Jia CC, Xu J, Li DH, Xu FX, Bai J, Li ZL, Hua HM Fitoterapia 2017. 119:83-89
	Effects of Silymarin on Diabetes Mellitus Complications: A Review Stolf AM, Cardoso CC, Acco A Phytother Res 2017. 31(3):366-374
	Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor Gu M, Zhao P, Huang J, Zhao Y, Wang Y, Li Y, Li Y, Fan S, Ma YM, Tong Q, Yang L, Ji G, Huang C Front Pharmacol 2016. 7:345
	Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects Pereira TM, Pimenta FS, Porto ML, Baldo MP, Campagnaro BP, Gava AL, Meyrelles SS, Vasquez EC Int J Mol Sci 2016. 17(8):E1273
	Effect of supplement containing Silybum marianum extract, soy extract, collagen peptide, bifidobacteria and apple extract on skin: A randomized placebo-controlled, double-blind, parallel group comparative clinical study Ishii Y, Okada Y, Matsuoka S, Shen M, Yui K, Yagi M, Yonei Y Glycat Stress Res 2016. 3(3):156-171
	Chemical and Biological Aspects of Extracts from Medicinal Plants with Antidiabetic Effects Gushiken LF, Beserra FP, Rozza AL, Bergamo PL, Bergamo DA, Pellizzon CH Rev Diabet Stud 2016. 13(2-3):96-112
	Milk thistle: new perspectives for an old remedy Kazazis C, Geladari E, Trigkidis K, Vallianou NG Curr Top Nutraceut Res 2016. 14(2):103-107
	Milk Thistle: Its Anti-Tumor Potential Kazazis C, Geladari E, Trigkidis K, Vallianou NG Hosp Chronicals 2016. 11(3):147-152
	Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease Hernandez-Rodas MC, Valenzuela R, Videla LA Int J Mol Sci 2015. 16(10):25168-25198
	Taraxacum officinale and Silybum marianum alone or combined orchestrate experimentally induced hepatic steatosis through lipogenecity, glucose tolerance and oxidant/antioxidant status Soliman NA, El-Dardiry SA Int J Biol Chem Sci 2015. 9(4):1918-1928
	Effect of Silymarin Supplementation on Glycemic Control, Lipid Profile and Insulin Resistance in Patients with Type 2 Diabetes Mellitus Elgarf AT, Mahdy MM, Sabri NA Int J Adv Res 2015. 3(12):812-821